LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 18.04 | 21.74 | 2 | 750 | 0.0027 | -0.3731 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 18.04 | 21.74 | 863 | 750 | 1.1498 | 1.0554 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 20.01 | 21.74 | 174 | 901 | 0.1929 | 0.4725 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 20.01 | 21.74 | 901 | 901 | 0.9990 | 0.9996 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 20.01 | 21.74 | 8 | 901 | 0.0089 | -0.1697 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 20.01 | 21.74 | 848 | 901 | 0.9402 | 0.9772 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 21.98 | 21.74 | 212 | 1108 | 0.1913 | 0.4941 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 21.98 | 21.74 | 909 | 1108 | 0.8201 | 0.9313 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 21.98 | 21.74 | 1 | 1108 | 0.0009 | -0.4189 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 21.98 | 21.74 | 849 | 1108 | 0.7660 | 0.9082 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 23.95 | 21.74 | 413 | 1354 | 0.3049 | 0.6387 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 23.95 | 21.74 | 907 | 1354 | 0.6696 | 0.8699 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 23.95 | 21.74 | 1 | 1354 | 0.0007 | -0.4034 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 23.95 | 21.74 | 873 | 1354 | 0.6445 | 0.8579 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 25.92 | 21.74 | 532 | 1515 | 0.3510 | 0.6857 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 25.92 | 21.74 | 934 | 1515 | 0.6162 | 0.8480 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 25.92 | 21.74 | 1 | 1515 | 0.0007 | -0.3952 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 25.92 | 21.74 | 883 | 1515 | 0.5826 | 0.8311 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 27.89 | 21.74 | 657 | 1677 | 0.3918 | 0.7223 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 27.89 | 21.74 | 952 | 1677 | 0.5677 | 0.8273 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 27.89 | 21.74 | 3 | 1677 | 0.0018 | -0.2709 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 27.89 | 21.74 | 888 | 1677 | 0.5295 | 0.8071 | MN20160310_N01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 29.86 | 21.74 | 757 | 1887 | 0.4012 | 0.7355 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 29.86 | 21.74 | 982 | 1887 | 0.5204 | 0.8071 | MN20160310_N01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 29.86 | 21.74 | 1 | 1887 | 0.0005 | -0.3801 | MN20160310_N01 | N12 |